Plus   Neg

Stock Alert: NextCure Tumbles To New 52-week Low

Shares of NextCure, Inc. (NXTC) are losing more than 41 percent or $7.36 in Monday's morning trade at $10.52, after earlier touching a new 52-week low of $10.45.

Monday, Beltsville, Maryland-based NextCure NextCure provided an interim update of the Phase 2 portion of its NC318 Monotherapy phase 1/2 trial.

NextCure said that based on current enrolment criteria and clinical response data, it does not plan to advance the non-small cell lung cancer or NSCLC and ovarian cancer cohorts into the stage 2 portion of the Simon 2-stage trial. The biotechnology company noted that the analysis of biomarker data for these cohorts has been delayed and is not yet complete.

In addition, NextCure said that its chief medical officer Kevin Heller has resigned, effective August 4, 2020 to pursue a new opportunity. Dr. Heller will serve as a consultant to the company. The company has initiated a search for a new chief medical officer.

NextCure has traded in a range of $10.45 to $109.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NASA's Osiris-Rex robotic spacecraft briefly touched down on near-Earth asteroid Bennu's surface on Tuesday to collect rock and dust samples that will be brought back to Earth in 2023. Bennu is currently more than 200 million miles, or 321 million kilometres, from Earth. Osiris-Rex launched from Cape Canaveral Air Force Station in Florida in September 2016. Amazon said Wednesday that free one-hour grocery pickup is now available to prime members at all U.S. Whole Foods Market locations. Previously, the prime members could pick up Whole Foods orders only at select stores. J.C. Penney said it is near to exiting Chapter 11 ahead of the busy December 2020 holiday season. The beleaguered retailer filed a draft asset purchase agreement towards finalization of the acquisition by Brookfield Asset Management, Inc. and Simon Property Group, Inc. They are expected to buy substantially all of J.C. Penney's retail and operating assets in a combination of cash and debt.
Follow RTT